Biocon Biologics partners IDF to increase access to diabetes care
Becomes the first biosimilar insulin company to partner with International Diabetes Federation for enabling affordable access to insulins to people with diabetes worldwide
Becomes the first biosimilar insulin company to partner with International Diabetes Federation for enabling affordable access to insulins to people with diabetes worldwide